Mycophenolate mofetil following intolerance or failure of thiopurine therapy in inflammatory bowel diseases

被引：0

作者：

McDermott, E. ^{[1
]}

Keegan, D. ^{[1
]}

Hall, B. ^{[1
]}

Mhuruchu, E. N. ^{[1
]}

Murphy, S. ^{[1
]}

Doherty, G. ^{[1
]}

O'Donoghue, D. ^{[1
]}

Mulcahy, H. ^{[1
]}

机构：

[1] Univ Coll Dublin, St Vincents Univ Hosp, Ctr Colorectal Dis, Dublin 4, Ireland

来源：

ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2011年 / 34卷 / 08期

关键词：

CROHNS-DISEASE; AZATHIOPRINE; EFFICACY;

D O I：

10.1111/1365-2036.2011.04825.x

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1040 / 1042

页数：3

共 6 条

[1]

Fellermann K, 2000, ALIMENT PHARM THER, V14, P171

[2]

Miehsler W, 2001, AM J GASTROENTEROL, V96, P782

[3] Review article: the role of non-biological drugs in refractory inflammatory bowel disease [J].

Ng, S. C. ;

Chan, F. K. L. ;

Sung, J. J. Y. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (04) :417-427

[4]

Orth T, 2000, AM J GASTROENTEROL, V95, P1201

[5] Mycophenolate mofetil therapy for refractory inflammatory bowel disease [J].

Palaniappan, S. ;

Ford, A. C. ;

Greer, D. ;

Everett, S. M. ;

Chalmers, D. M. ;

Axon, A. T. R. ;

Hamlin, P. J. .

INFLAMMATORY BOWEL DISEASES, 2007, 13 (12) :1488-1492

[6] Mycophenolate mofetil for Crohn's disease: short-term efficacy and long-term outcome [J].

Wenzl, HH ;

Hinterleitner, TA ;

Aichbichler, BW ;

Fickert, P ;

Petritsch, W .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (04) :427-434

← 1 →